Review Article

MicroRNAs in Soft Tissue Sarcomas: Overview of the Accumulating Evidence and Importance as Novel Biomarkers

Figure 1

Examples of clinical applications of miRNAs as biomarkers and therapeutics for patients with soft tissue sarcoma. As therapeutics: ① combination with neoadjuvant chemotherapy, ② combination with adjuvant chemotherapy, and ③ combination with chemotherapy for metastasis. As biomarkers: diagnosis, determination of drug resistance, monitoring after treatment for primary lesions, detection for micrometastasis, and monitoring after treatment for metastasis. ADR: adriamycin; IFO: ifosfamide; GEM: gemcitabine; DOC: docetaxel.
592868.fig.001